1900 |
당뇨병/비만/지질 |
|
Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus.
|
Yong Ho Lee |
Frontiers in neuroscience |
2021/00 |
1899 |
당뇨병/비만/지질 |
|
Serum 25-hydroxyvitamin D and Metabolic Parameters in Healthy Korean Adults: Korean National Health and Nutrition Examination Survey VI.
|
Dong Jun Lim,Kang Moo Il |
International journal of general medicine |
2021/00 |
1898 |
당뇨병/비만/지질 |
|
Influence of FMO3 and CYP3A4 Polymorphisms on the Pharmacokinetics of Teneligliptin in Humans
|
Kim Kyoung Ah |
Frontiers in pharmacology |
2021/00 |
1897 |
당뇨병/비만/지질 |
|
Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors.
|
Hae Jin Kim |
Frontiers in pharmacology |
2021/00 |
1896 |
당뇨병/비만/지질 |
|
Pleiotropic Benefits of DPP-4 Inhibitors Beyond Glycemic Control.
|
Jeong Hyun Park,Kang Seon Mee |
Clinical medicine insights. Endocrinology and diabetes |
2021/00 |
1895 |
당뇨병/비만/지질 |
|
Identification of Cardiovascular Risk Factors in Obese Adolescents With Metabolic Syndrome.
|
Hae Soon Kim |
Frontiers in pediatrics |
2021/00 |
1894 |
당뇨병/비만/지질 |
|
Brain Structural Alterations, Diabetes Biomarkers, and Cognitive Performance in Older Adults With Dysglycemia.
|
Bo Kyung Koo,Min Kyong Moon |
Frontiers in neurology |
2021/00 |
1893 |
당뇨병/비만/지질 |
|
Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease.
|
Ku Bon Jeong |
Computational and structural biotechnology journal |
2021/00 |